2.1. Study design
This trial is a single-center, randomized, assessor-blinded, controlled study. We will recruit 40 POP patients and assign them to the control group (conventional medication and health education) and the experimental group (personalized exercise prescription based on Yijinjing) in a 1:1 ratio according to the intended protocol. Before randomization, all patients were required to sign an informed consent form. The flow chart of the study is shown in Figure Flow chart of the study.SPIRIT figure as recommended by 2013 SPIRIT statement.